Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD

Delayed Quote. Delayed  - 05/02 09:09:34 pm
10.69 USD   +2.30%
04/28 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Iro..
04/28 Pomerantz Law Firm Investigates Claims On Behalf of Investors of ..
04/28 IMPORTANT SHARE : Goldberg Law PC Announces an Investigation of Clai..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Most relevant news about IRONWOOD PHARMACEUTICALS,
04/28 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ironwood Pharma..
04/28 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ironwood Pha..
04/28 IMPORTANT SHAREHOLDER NOTICE : Goldberg Law PC Announces an Investigation of Cla..
04/27 Ironwood Pharmaceuticals & ResMed, are Worth Watching Stocks
04/27 Investigation of Ironwood Pharmaceuticals, Inc. Announced by Law Offices of H..
04/26 IRONWOOD PHARMACEUTICALS : Investigated for Potential Violations of Federal Secu..
04/26 ASTRAZENECA : and Ironwood sign Zurampic licensing agreement
04/26 ASTRAZENECA : sells U.S. gout drug rights to Ironwood for up to $265 million
04/26 ASTRAZENECA : AZ enters US licensing agreement with Ironwood
04/26DJASTRAZENECA : Signs U.S. Licensing Pact for Gout Drug
04/26 IRONWOOD PHARMACEUTICALS : Enters into U.S. Licensing Agreement with AstraZeneca..
04/26 UPDATE : AstraZeneca Inks Zurampic Licensing Deal For US With Ironwood
04/25 IRONWOOD PHARMACEUTICALS : to Host First Quarter 2016 Investor Update Call
04/07 IRONWOOD PHARMACEUTICALS : Appoints Andrew Dreyfus to Board of Directors
04/05 IRONWOOD PHARMACEUTICALS : Schwab Charles Investment Management Inc. Boosts Posi..
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
04/28 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ironwood Pharma..
04/28 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ironwood Pha..
04/28 IMPORTANT SHAREHOLDER NOTICE : Goldberg Law PC Announces an Investigation of Cla..
04/27 Ironwood Pharmaceuticals & ResMed, are Worth Watching Stocks
04/27 Investigation of Ironwood Pharmaceuticals, Inc. Announced by Law Offices of H..
04/26 IRONWOOD PHARMACEUTICALS : Investigated for Potential Violations of Federal Secu..
04/26 IRONWOOD PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Finan..
04/26 ASTRAZENECA : and Ironwood sign Zurampic licensing agreement
04/26 ASTRAZENECA : sells U.S. gout drug rights to Ironwood for up to $265 million
04/26 ASTRAZENECA : AZ enters US licensing agreement with Ironwood
More news
Sector news : Biotechnology & Medical Research - NEC
07:08p GENMAB A/S : Articles of Association for Genmab A/S
04:03p SANOFI : Comments on Medivation's Rejection of acquisition Proposal
01:01p REGENERON PHARMACEUTICALS : Announces Positive Topline Results from Phase 2/3 Fa..
01:01p QUINTILES TRANSNATIONAL : Novogen Provides Update On Development Of Cantrixil
05/01 BRIEF : Sanofi girds for another fight
04/29 SANOFI : offers to buy Medivation for $9.3bn
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
04/27 UNCOVERED : Safety Issues Linked With Ironwood's Drug, Linzess
04/27 BIOTECH FORUM DAILY DIGEST : Sarepta Plunges On Ad Comm Decision, Novartis To Be..
04/26 HEDGED RELYPSA LONGS : Consider This Course Correction
04/26 Ironwood Pharma nabs U.S. rights to AstraZeneca gout drug Zurampic
04/18 BIOTECH DAILY DIGEST : Government To The Rescue For Gilead? Decision Day Approac..
04/08 Healthcare ratings roundup


Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials